BCAL Diagnostics Limited (AU:BDX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BCAL Diagnostics Limited has announced a new proposal to issue 62 million ordinary fully paid securities, with the target date for issuing set for June 11, 2024. This move, pending approval from the ASX for quotation on a deferred settlement basis, could potentially stimulate investor interest and impact the company’s market dynamics.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.